Jul 2026
Beyond mild myopia: a pilot randomized trial of 0.01% atropine in school-aged children with myopia ≤ -4.50 D.
In the present cohort, 0.01% atropine suppressed myopia progression over 12 months, with inhibition ratios similar to previous trials involving mild to moderate myopia, which support the feasibility of low-dose atropine for advanced myopia and justify full-scale trials.
Eizo Tanaka, Yuki Morizane, S. Fujii et al.
· Japanese Journal of Ophthalm... · 0 citations